Skip to main content
Premium Trial:

Request an Annual Quote

Natera Prices $250M Public Stock Offering

NEW YORK – Natera said late on Thursday that it has priced the $250 million public stock offering announced earlier this week. The company is offering 4,166,666 shares of its common stock at a price of $60 per share.

The follow-on offering is expected to close on Sept. 15, subject to customary closing conditions.

The underwriters have a 30-day option to purchase up to another 624,999 shares of Natera's common stock at the public offering price, less the underwriting discounts and commissions.

As previously announced, JP Morgan, Morgan Stanley, Cowen, and SVB Leerink are acting as joint book-running managers for the offering, while Baird and Craig-Hallum Capital Group are acting as co-managers.

In morning trading on the Nasdaq, Natera's stock was down 3 percent, at $59.83 per share.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.